Valencia-Olvera, Ana C.
Balu, Deebika
Bellur, Shreya
McNally, Thomas
Saleh, Yaseen
Pham, Don
Ghura, Shivesh
York, Jason
Johansson, Jan O.
LaDu, Mary Jo
Tai, Leon
Funding for this research was provided by:
National Institutes of Health (NIH R21 AG051233-01, NIH R21 AG051233-01, NIH R21 AG051233-01, NIH R21 AG051233-01, NIH R21 AG051233-01)
University of Illinois College of Medicine (Institutional funds, Institutional funds, Institutional funds, Institutional funds, Institutional funds, Institutional funds, Institutional funds, Institutional funds, Institutional funds)
Lou and Christine Friedrich (Philanthropic support, Philanthropic support, Philanthropic support, Philanthropic support)
University of Illinois at Chicago (Honors College Undergraduate Research Award, Honors College Undergraduate Research Award, Honors College Undergraduate Research Award, Honors College Undergraduate Research Award)
National Institute on Aging (R01AG061114)
Article History
Received: 15 September 2023
Accepted: 15 November 2023
First Online: 15 December 2023
Declarations
:
: Not applicable.
: Not applicable.
: This project was not in any way financed by Artery Therapeutics. All academic researchers in the research group are not involved with Artery Therapeutics. JOJ is a founder and CEO of Artery Therapeutics, Inc. JOJ receives a salary from and holds stock in Artery Therapeutics. JOJ is a co-inventor of CS6253 composition of matter and method of use patents. The relevant US patent is US 9416162 B2 with JJ as an inventor. This does not alter the authors' decisions on experimental designs, execution, analysis, and adherence to all the publication policies on sharing data and materials. The authors declare no other competing financial interests.